Alessandro Sanitin/LinkedIn
Apr 7, 2026, 13:50
Alessandro Santin Discusses New Targets in Rare Endometrial Disease – Yale Obstetrics, Gynecology and Reproductive Sciences
Yale Obstetrics, Gynecology and Reproductive Sciences shared a post on LinkedIn:
” ‘It’s only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets,’ says our own Yale Ob/Gyn’s Alessandro Sanitin, MD.
In an interview with Contemporary OB/GYN, Dr. Santin discusses his investigation of new treatments for rare endometrial disease.
Read and/or listen here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 24, 2026, 19:45Danielle Uses Her Voice and Story to Help Create Change – Preeclampsia Foundation
-
May 24, 2026, 19:42Jakub Dejewski: Looking Back at The Fertility Show at Olympia London
-
May 24, 2026, 09:50Sima Alnamoora: Day 5 Early Hatching Blastocyst Captured During IVF Cycle Monitoring
-
May 24, 2026, 07:29Lucile Ferreux: The Hidden Reality of Male Fertility, Have You Ever Had a Spermiogram?
-
May 24, 2026, 07:25Cesar Fertility Newsletter Highlights Lifestyle Impact on Male Fertility Awareness – Cesar Fertility
-
May 24, 2026, 07:21Carla Wicks: Understanding Racial Differences in Endometriosis Care Pathways
-
May 24, 2026, 07:14Why Do French Men Go 20 to 30 Years Without Any Genital Examination? – Cesar Fertility
-
May 24, 2026, 07:11Lucile Ferreux: Sperm Racing Event Sparks Debate on Male Fertility Awareness and Scientific Accuracy
-
May 24, 2026, 07:08Unlocking the Black Box of Implantation Failure with Multi-Dimensional AI in IVF – Santaan Fertility Center and Research Institute